平特五不中

We鈥檝e moved

The Rosalind and Morris Goodman Cancer Institute can now be found at

GCI researchers were highly successful in the Canadian Institutes of Health Research (CIHR) Project Grant Fall 2022 Competition

We are pleased to announce that 7 of our PIs received funding from the CIHR Project Grant Fall 2022 competition for their respective research projects. The national success rate for this competition was 20.1%; the Quebec provincial success rate was 23.7%; and the success rate of the GCI was 57%.

Congratulations to GCI Professors Luke McCaffrey, William Muller, Arnim Pause, Jerry Pelletier, Peter Siegel, Jose Teodoro and Ian Watson, who received a combined $6,035,661, either from a Project Grant or Bridge funding.

Projects Include:

Luke McCaffrey:听Characterizing tissue-intrinsic barriers to malignant transformation in the breast epithelium

William Muller: The multifaceted role of c-Src tyrosine kinase in breast cancer progression;听Chi3L1 (YKL-40) plays a multifaceted role in modulating tumour immune microenvironment during breast cancer progression (Bridge)

Arnim Pause:听Characterization of human TFE3 isoforms as drivers in breast cancer听(Bridge)

Jerry Pelletier:听Eukaryotic Initiation Factor 4F - A Strategic Driver of the Cellular Information Network

Peter Siegel:听Defining the immunomodulatory role of GPNMB in triple-negative breast cancer

Jose Teodoro:听Targeting the RNA translatome to enhance anti-mitotic chemotherapy听(Bridge)

Ian Watson:听Identification of biomarkers using single cell technology that inform on optimal duration of immunotherapy treatment in melanoma

Back to top